Literature DB >> 11594953

Effects of cyclosporin A on human conjunctival fibroblasts.

A Leonardi1, G DeFranchis, I A Fregona, D Violato, M Plebani, A G Secchi.   

Abstract

OBJECTIVE: To evaluate the effects of cyclosporin A (CsA) on cytokine and/or collagen production, cell growth, and apoptosis in conjunctival fibroblast cultures.
METHODS: Fibroblast cultures derived from normal subjects and patients with vernal keratoconjunctivitis and pemphigoid were exposed to different concentrations of CsA for either 24 hours or 30 days. The effects were evaluated by the colorimetric MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) test to assess cell proliferation, and by the measurement of procollagen I (PIP) and procollagen III (PIIIP) cytokines and total protein in culture medium. CsA-induced apoptosis was assessed by fluorescence-activated cell sorter analysis.
RESULTS: After 24 hours of exposure to doses of CsA of more than 10 microg/mL, cell proliferation and migration were significantly reduced. Cyclosporin A reduced PIP and interleukin 1 (IL-1) production in a dose-dependent manner. Interleukin 6 and IL-8 were increased by 10 microg/mL of CsA, whereas transforming growth factor beta, PIIIP, and total protein were unaffected. Cyclosporin A exposure induced apoptosis in a time- and dose-dependent manner. Long-term exposure to CsA reduced IL-6 but did not modify PIIIP production.
CONCLUSION: Exposure to CsA directly modified fibroblast behavior. CLINICAL RELEVANCE: Cyclosporin A ability to accelerate apoptosis in clinically fibrotic tissues may prove to be therapeutic and useful in hyperproliferative conjunctival disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11594953     DOI: 10.1001/archopht.119.10.1512

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  9 in total

1.  Effects of daunorubicin, mitomycin C, azathioprine and cyclosporin A on human retinal pigmented epithelial, corneal endothelial and conjunctival cell lines.

Authors:  Justus G Garweg; Maria Wegmann-Burns; David Goldblum
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-10       Impact factor: 3.117

Review 2.  Topical ciclosporin in the treatment of ocular surface disorders.

Authors:  S Tatlipinar; E K Akpek
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

3.  Modern approach to managing vernal keratoconjunctivitis.

Authors:  Sunil Kumar; Nitin Gupta; Anthony J Vivian
Journal:  Curr Allergy Asthma Rep       Date:  2010-05       Impact factor: 4.806

Review 4.  [Ocular allergies].

Authors:  E M Messmer
Journal:  Ophthalmologe       Date:  2005-05       Impact factor: 1.059

Review 5.  [Therapeutic options in vernal keratoconjunctivitis].

Authors:  E M Messmer
Journal:  Ophthalmologe       Date:  2009-06       Impact factor: 1.059

Review 6.  Cyclosporine A: Novel concepts in its role in drug-induced gingival overgrowth.

Authors:  Deepa Ponnaiyan; Visakan Jegadeesan
Journal:  Dent Res J (Isfahan)       Date:  2015 Nov-Dec

7.  PLA-PEG Implant as a Drug Delivery System in Glaucoma Surgery: Experimental Study.

Authors:  Viktoriya N Germanova; Elena V Karlova; Larisa T Volova; Andrey V Zolotarev; Viktoriya V Rossinskaya; Ivan D Zakharov; Aleksandr R Korigodskiy; Violetta V Boltovskaya; Irina F Nefedova; Mariya V Radaykina
Journal:  Polymers (Basel)       Date:  2022-08-21       Impact factor: 4.967

8.  P-glycoprotein Blockers Augment the Effect of Mitomycin C on Human Tenon's Fibroblasts.

Authors:  Andrew J R White; Elizabeth Kelly; Paul R Healey; Jonathan G Crowston; Paul Mitchell; Hans Zoellner
Journal:  Transl Vis Sci Technol       Date:  2013-06-28       Impact factor: 3.283

9.  Proliferative and inductive effects of Cyclosporine a on gingival fibroblast of child and adult.

Authors:  Bahareh Nazemi Salman; Surena Vahabi; Sepideh Ebrahimi Movaghar; Faranak Mahjour
Journal:  Dent Res J (Isfahan)       Date:  2013-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.